By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hospira, Inc. 

275 North Field Drive
Lake Forest  Illinois  60045  U.S.A.
Phone: 224-212-2000 Fax: n/a

Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing and marketing products that improve the productivity, safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories in April 2004, Hospira has a 70-year history of service to the hospital industry.

In February 2007, Hospira acquired MaynePharma Limited to become the world leader in specialty generic injectable pharmaceuticals. Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare – to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety. Its portfolio includes one of the industry's broadest lines of generic acutecare and oncology injectables, and integrated solutions for medication management and infusion therapy.

Nine manufacturing facilities in the United States include: Ashland, Ohio; Austin, Texas; Boulder, Colo.; Buffalo, N.Y.; Clayton, N.C.; McPherson, Kan.; Morgan Hill, Calif.; Rocky Mount, N.C. Nine facilities outside the United States include: Aguadilla, Puerto Rico; Haina, Dominican Republic; La Aurora de Heredia, Costa Rica; Liscate, Italy; Montreal, Canada; Mulgrave, Australia; Salisbury, Australia; Sligo, Ireland; and Wasserburg, Germany.

• John C. Staley, Chairman of the Board of Directors
• Mike Ball, Chief Executive Officer (CEO)

Hospira has established long-standing customer relationships that span the "continuum of care" (hospitals, alternate site facilities, home healthcare providers and long-term care facilities).

Hospira has a leading position in the manufacture and supply of a broad range of hospital products including:

• Specialtyinjectables (including generic acute-care and oncology injectables, intensive-care proprietary pharmaceuticals, as well as proprietary delivery systems such as the iSecure™ syringe, a pre-filled, ready-to-use, disposable syringe)
• Medication management systems (including electronic infusion pumps and the HospiraMedNet® software system)
• Infusion therapy solutions/supplies (including the VisIV™ next-generation container)
• Critical care devices
• Third-party contract manufacturing, which leverages Hospira's expertise in pharmaceutical manufacturing

Hospira's news releases and other information can be found at

Key Statistics

Ownership: Public

Web Site: Hospira
Employees: Approximately 15,000 employees worldwide


Company News
Hospira's Hospital Drug Pump Can Be Hacked Through Network, FDA Warns 8/3/2015 6:09:31 AM
Hospira Reports Second-Quarter 2015 Results 7/30/2015 10:08:21 AM
10 Biotech Firms Rapidly Expanding in North Carolina 7/21/2015 5:01:57 AM
Hospira Announces U.S. Launch Of Generic Bivalirudin For Injection 7/17/2015 6:26:34 AM
Hospira To Announce Second-Quarter 2015 Results On July 29, 2015 7/16/2015 11:43:15 AM
New Results From First Real-World Study Show Comparable Effectiveness And Safety Of Hospira's Inflectra (infliximab) In Patients With Rheumatic Diseases Switched From Reference infliximab, Remicade 6/10/2015 6:16:30 AM
Hospira Release: ANVISA Approves First Infliximab Biosimilar In Brazil 6/2/2015 11:16:56 AM
Theradiag And Hospira Sign A Partnership Agreement 5/20/2015 9:33:47 AM
Hospira, Alliance For Health Reform Bring Food And Drug Administration, Industry Experts Together To Discuss The Future Of Biosimilars In The United States 5/20/2015 7:48:21 AM
Pfizer (PFE) Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira 5/14/2015 10:52:49 AM